Vesale Pharma Woman Health SRL
Vesale Pharma Woman Health reported total assets of 62,158 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Vesale Pharma Woman Health shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +1115 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vesale Pharma Woman Health's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Vesale Pharma Woman Health's financial analysis
- Solvency-27.6%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vesale Pharma Woman Health
Vesale Pharma Woman Health's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0658.893.086
- VAT number
- BE0658893086
- Peppol
- Registered · 0208:0658893086 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jul 2016
- Registered office
- 5310 Éghezée
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vesale Pharma Woman Health (SRL) has been based in Éghezée since 2016, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 4,020 € and equity of −17,173 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vesale Pharma Woman Health
Companies in the same business, of comparable size and area, outside its group.
- Fortilab Manufacture of pharmaceutical preparations Etterbeek · balance sheet €1.39m
- AIP Medical Manufacture of pharmaceutical preparations Olne · balance sheet €1.64m
- Pannoc Chemie Manufacture of pharmaceutical preparations Olen · balance sheet €2.32m
- HEW Pharma Manufacture of pharmaceutical preparations Kalmthout · balance sheet €1.01m
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- Fagron Belgium Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €7.86m
- Bofar Wholesale of pharmaceutical and medical goods Wingene · balance sheet €12.2m
Frequently asked questions about Vesale Pharma Woman Health
What is the revenue of Vesale Pharma Woman Health?
Vesale Pharma Woman Health files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vesale Pharma Woman Health?
In Belgium, the VAT number is the company number prefixed with BE: BE0658893086 for Vesale Pharma Woman Health, if the company is VAT-registered. Its company number (CBE) is 0658.893.086.
Where is the registered office of Vesale Pharma Woman Health?
According to the CBE register, the registered office of Vesale Pharma Woman Health is in 5310 Éghezée.
What is the equity of Vesale Pharma Woman Health?
At the close of the 2025 financial year, the equity of Vesale Pharma Woman Health amounts to -17,173 €, a solvency of -27.6% of total assets.
Who manages Vesale Pharma Woman Health?
The register lists 3 active mandates at Vesale Pharma Woman Health. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vesale Pharma Woman Health
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →